Pfizer, Astellas prostrate cancer drug clears late-stage trial

Sept 14 (Reuters) - Pfizer Inc and Astellas Pharma Inc said on Thursday their drug to treat a type of prostrate cancer met the main goal of improving overall survival in a late-stage trial.

Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

Fed chair Janet Yellen to step down

Yellen's decision to quit the board leaves four spots open, paving the way for President Donald Trump to further reshape the nation's monetary policymaking.

0 0

Whoops, looks like something went wrong.